Karen M. Lammers - Concepedia

Author

Karen M. Lammers

Also Known As

K LAMMERS, K Lammers, K M Lammers, K. Lammers, K. M. LAMMERS, K.M. Lammers, KAREN M. LAMMERS, Karen Lammers, Karen M Lammers, Karen M. Lammers

Publications

5.3K

Citations

H-Index

Concepts

All Affiliations

University of Maryland, Baltimore Procter & Gamble (United States)University of Bologna IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola Massachusetts General Hospital

About

Karen M. Lammers is an author at University of Maryland, Baltimore specializing in medicine, immunology, and inflammation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	3K
2	Cell Biology	5	5	1.3K
3	Allergy	3	3	498
4	Health Sciences	1	1	437
5	Language Studies	1	1	65

Karen M. Lammers

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial Paolo Gionchetti, Fernando Rizzello, Ulf Helwig, Gastroenterology ProbioticDysbiosisAntimicrobial SusceptibilityAntibiotic AdjuvantPlacebo-controlled Trial	2003	1.1K
Gliadin Induces an Increase in Intestinal Permeability and Zonulin Release by Binding to the Chemokine Receptor CXCR3 Karen M. Lammers, Ruliang Lu, Julie Brownley, Gastroenterology InflammationIntestinal PermeabilityZonulin ReleaseSignal TransductionChemokine Receptor Cxcr3	2008	527
Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity Anna Sapone, Karen M. Lammers, Vincenzo Casolaro, BMC Medicine	2011	444
Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2 Amit Kumar Tripathi, Karen M. Lammers, Simeon E. Goldblum, Proceedings of the National Academy of Sciences Intestinal PermeabilityNeurotransmitterImmunologyCytoskeletonHuman Zonulin	2009	437
Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells Karen M. Lammers, Patrizia Brigidi, Beatrice Vitali, FEMS Immunology & Medical Microbiology ProbioticDysbiosisImmunomodulatory EffectsMucosal ImmunologyProbiotic Bacteria Dna	2003	284
The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT‐1001 in coeliac disease subjects: a proof of concept study Blake Paterson, Karen M. Lammers, Marie‐Claire Arrieta, Alimentary Pharmacology & Therapeutics	2007	281
Differential Mucosal IL-17 Expression in Two Gliadin-Induced Disorders: Gluten Sensitivity and the Autoimmune Enteropathy Celiac Disease Anna Sapone, Karen M. Lammers, Giuseppe Mazzarella, International Archives of Allergy and Immunology	2009	243
Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. Rogier Q. Hintzen, Susanne M.A. Lens, Karen M. Lammers, The Journal of Immunology Lymphocyte DevelopmentAdaptive Immune SystemT-regulatory CellImmunologyImmune Regulation	1995	242
Effect of probiotic strains on interleukin 8 production by HT29/19A cells Karen M. Lammers, Ulf Helwig, Erwin Swennen, The American Journal of Gastroenterology	2002	152
Restoration of impaired intestinal barrier function by the hydrolysed casein diet contributes to the prevention of type 1 diabetes in the diabetes-prone BioBreeding rat Jeroen Visser, Karen M. Lammers, AJ Hoogendijk, Diabetologia	2010	108

Page 1